Literature DB >> 9814708

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

J Nichols1, B Zevnik, K Anastassiadis, H Niwa, D Klewe-Nebenius, I Chambers, H Schöler, A Smith.   

Abstract

Oct4 is a mammalian POU transcription factor expressed by early embryo cells and germ cells. We report that the activity of Oct4 is essential for the identity of the pluripotential founder cell population in the mammalian embryo. Oct4-deficient embryos develop to the blastocyst stage, but the inner cell mass cells are not pluripotent. Instead, they are restricted to differentiation along the extraembryonic trophoblast lineage. Furthermore, in the absence of a true inner cell mass, trophoblast proliferation is not maintained in Oct4-/- embryos. Expansion of trophoblast precursors is restored, however, by an Oct4 target gene product, fibroblast growth factor-4. Therefore, Oct4 also determines paracrine growth factor signaling from stem cells to the trophectoderm.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814708     DOI: 10.1016/s0092-8674(00)81769-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1084 in total

1.  Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.

Authors:  A Brehm; K Ohbo; W Zwerschke; V Botquin; P Jansen-Dürr; H R Schöler
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Phagocytosis reveals a reversible differentiated state early in the development of the mouse embryo.

Authors:  M Rassoulzadegan; B S Rosen; I Gillot; F Cuzin
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo.

Authors:  Lynn A Hanna; Ruth K Foreman; Illya A Tarasenko; Daniel S Kessler; Patricia A Labosky
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

6.  Characteristics of a pluripotent population at early stages of embryonic stem cell differentiation in culture.

Authors:  O F Gordeeva; E S Manuilova; I A Grivennikov; D V Gulyaev; YuA Smirnova; R D Zinov'eva; N G Khrushchov
Journal:  Dokl Biol Sci       Date:  2002 Sep-Oct

7.  Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.

Authors:  Tetsuya S Tanaka; Tilo Kunath; Wendy L Kimber; Saied A Jaradat; Carole A Stagg; Masayuki Usuda; Takashi Yokota; Hitoshi Niwa; Janet Rossant; Minoru S H Ko
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

8.  Ectopic expression of GATA6 bypasses requirement for Grb2 in primitive endoderm formation.

Authors:  Ying Wang; Jennifer L Smedberg; Kathy Qi Cai; D Callinice Capo-Chichi; Xiang-Xi Xu
Journal:  Dev Dyn       Date:  2010-10-05       Impact factor: 3.780

9.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 10.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.